KNSA
Kiniksa Pharmaceuticals International, plc
Company overview
- Market capitalization
- $11.88B
- Employees
- 366
- Latest publication
- 2026-09-29
About Kiniksa Pharmaceuticals International, plc
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobulin G2 monoclonal antibody, which is Phase 2/3 clinical trial for the treatment of recurrent pericarditis; and KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody, which is in pre-clinical stage. The company was formerly known as Kiniksa Pharmaceuticals, Ltd. and changed its name to Kiniksa Pharmaceuticals International, plc in June 2024. Kiniksa Pharmaceuticals International, plc was incorporated in 2015 and is based in London, the United Kingdom.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q2 20242024-06-30 · USD | Q4 20232023-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 243,600,000USD | 214,266,000USD | 202,127,000USD | 180,855,000USD | 156,797,000USD | 137,785,000USD | 108,631,000USD | 83,395,000USD |
| Cost Of Revenue | 23,572,000USD | 96,373,000USD | 91,096,000USD | 83,591,000USD | 71,021,000USD | 61,658,000USD | 42,455,000USD | 26,759,000USD |
| Gross Profit | 220,028,000USD | 117,893,000USD | 111,031,000USD | 97,264,000USD | 85,763,000USD | 76,127,000USD | 66,176,000USD | 56,636,000USD |
| Research Development | 40,899,000USD | 27,475,000USD | 34,636,000USD | 24,139,000USD | 18,753,000USD | 19,325,000USD | 23,898,000USD | 19,816,000USD |
| Selling General Administrative | 63,866,000USD | 61,151,000USD | 56,775,000USD | 49,104,000USD | 46,863,000USD | 43,530,000USD | 42,395,000USD | 36,739,000USD |
| Total Operating Expenses | 192,834,000USD | 88,626,000USD | 91,263,000USD | 73,243,000USD | 65,616,000USD | 62,855,000USD | 66,293,000USD | 56,555,000USD |
| Operating Income | 27,194,000USD | 29,267,000USD | 19,768,000USD | 24,021,000USD | 20,160,000USD | 13,272,000USD | -117,000USD | 81,000USD |
| Total Other Income Expense Net | 3,951,000USD | 3,414,000USD | 3,501,000USD | 3,136,000USD | 2,717,000USD | 2,293,000USD | 2,421,000USD | 2,369,000USD |
| Income Before Tax | 31,145,000USD | 32,681,000USD | 23,269,000USD | 27,157,000USD | 22,877,000USD | 15,565,000USD | 2,304,000USD | 2,450,000USD |
| Income Tax Expense | 5,713,000USD | 10,089,000USD | 9,070,000USD | 8,722,000USD | 5,045,000USD | 7,026,000USD | 6,212,000USD | -22,787,000USD |
| Net Income | 25,432,000USD | 22,592,000USD | 14,199,000USD | 18,435,000USD | 17,832,000USD | 8,539,000USD | -3,908,000USD | 25,237,000USD |
| Tax Provision | — | 10,089,000USD | 9,070,000USD | 8,722,000USD | 5,045,000USD | 7,026,000USD | 6,212,000USD | -22,787,000USD |
| Net Income From Continuing Ops | — | 22,592,000USD | 14,199,000USD | 18,435,000USD | 17,832,000USD | 8,539,000USD | -3,908,000USD | 25,237,000USD |
| Ebit | — | 32,681,000USD | 23,269,000USD | 27,157,000USD | 22,877,000USD | 15,565,000USD | 2,304,000USD | 2,450,000USD |
| Ebitda | — | 33,149,000USD | 23,736,000USD | 27,541,000USD | 23,235,000USD | 15,910,000USD | 2,734,000USD | 2,686,000USD |
| Depreciation And Amortization | — | 468,000USD | 467,000USD | 384,000USD | 358,000USD | 345,000USD | 430,000USD | 236,000USD |
| Reconciled Depreciation | — | 468,000USD | 467,000USD | 384,000USD | 358,000USD | 345,000USD | 430,000USD | 540,000USD |
| Interest Expense | — | — | — | — | — | — | — | 1,832,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20222022-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 677,564,000USD | 220,180,000USD | 7,704,000USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 307,414,000USD | 22,895,000USD | 3,805,000USD | 3,279,000USD | 286,000USD | 28,000USD | 22,000USD |
| Gross Profit | 370,150,000USD | 197,285,000USD | -3,805,000USD | -3,279,000USD | -286,000USD | -28,000USD | -22,000USD |
| Research Development | 96,853,000USD | 65,490,000USD | 112,042,000USD | 135,001,000USD | 86,597,000USD | 56,357,000USD | 17,439,000USD |
| Selling General Administrative | 196,272,000USD | 97,951,000USD | 45,321,000USD | 34,962,000USD | 21,563,000USD | 9,043,000USD | 6,563,000USD |
| Total Operating Expenses | 292,929,000USD | 187,512,000USD | 157,363,000USD | 169,963,000USD | 108,160,000USD | 65,400,000USD | 24,002,000USD |
| Operating Income | 77,221,000USD | 9,773,000USD | -157,363,000USD | -169,963,000USD | -108,160,000USD | -65,400,000USD | -24,002,000USD |
| Income Before Tax | 88,868,000USD | 11,026,000USD | -156,229,000USD | -163,914,000USD | -103,441,000USD | -64,871,000USD | -23,937,000USD |
| Income Tax Expense | 29,863,000USD | -172,337,000USD | 5,152,000USD | -2,047,000USD | -214,000USD | 2,000USD | 36,000USD |
| Tax Provision | 29,863,000USD | -172,337,000USD | 5,152,000USD | -2,047,000USD | -214,000USD | 2,000USD | 36,000USD |
| Net Income | 59,005,000USD | 183,363,000USD | -161,381,000USD | -161,867,000USD | -103,227,000USD | -64,873,000USD | -23,973,000USD |
| Net Income From Continuing Ops | 59,005,000USD | 183,363,000USD | -161,381,000USD | -161,867,000USD | -103,227,000USD | -64,873,000USD | -23,973,000USD |
| Ebit | 88,868,000USD | 11,026,000USD | -157,363,000USD | -169,963,000USD | -108,160,000USD | -65,400,000USD | -24,002,000USD |
| Ebitda | 90,422,000USD | 13,428,000USD | -154,958,000USD | -167,895,000USD | -107,874,000USD | -65,372,000USD | -23,980,000USD |
| Depreciation And Amortization | 1,554,000USD | 2,402,000USD | 2,405,000USD | 2,068,000USD | 286,000USD | 28,000USD | 22,000USD |
| Reconciled Depreciation | 1,554,000USD | 2,402,000USD | 2,405,000USD | 2,068,000USD | 286,000USD | 28,000USD | — |
| Total Other Income Expense Net | 11,647,000USD | 1,253,000USD | 1,134,000USD | 6,049,000USD | 4,719,000USD | 529,000USD | 65,000USD |
| Unclassified Operating Expenses | — | 24,071,000USD | — | — | — | — | — |
| Interest Income | — | 1,253,000USD | 1,134,000USD | 6,049,000USD | 4,719,000USD | 529,000USD | 65,000USD |
| Interest Expense | — | 1,253,000USD | 3,539,000USD | 8,117,000USD | 0USD | 0USD | 0USD |
| Net Interest Income | — | 1,253,000USD | 1,134,000USD | 6,049,000USD | 4,719,000USD | 529,000USD | 65,000USD |
| Non Operating Income Net Other | — | 1,253,000USD | 1,134,000USD | 6,049,000USD | 4,719,000USD | — | — |
| Net Income Applicable To Common Shares | — | 183,363,000USD | -161,381,000USD | -161,867,000USD | -103,227,000USD | -64,873,000USD | -23,973,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 896,110,000USD | 825,280,000USD | 763,633,000USD | 712,333,000USD | 661,150,000USD | 599,326,000USD | 580,553,000USD | 555,298,000USD |
| Cash And Equivalents | 175,677,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 525,928,000USD | 468,093,000USD | 414,074,000USD | 352,102,000USD | 307,782,000USD | 268,340,000USD | 243,627,000USD | 223,780,000USD |
| Short Term Investments | 350,251,000USD | 278,141,000USD | 248,478,000USD | 177,244,000USD | 115,745,000USD | 111,208,000USD | 60,046,000USD | 126,404,000USD |
| Total Current Assets | 668,633,000USD | 594,172,000USD | 527,177,000USD | 475,530,000USD | 420,311,000USD | 355,907,000USD | 331,799,000USD | 311,301,000USD |
| Other Current Assets | 48,285,000USD | 29,714,000USD | 42,614,000USD | 30,290,000USD | 32,438,000USD | 25,433,000USD | 20,084,000USD | 33,953,000USD |
| Other Non Current Assets | 10,834,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 241,961,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 171,247,000USD | 156,611,000USD | 139,184,000USD | 123,592,000USD | 117,827,000USD | 97,267,000USD | 100,621,000USD | 95,955,000USD |
| Other Current Liabilities | 20,052,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 34,018,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 654,149,000USD | 605,687,000USD | 567,606,000USD | 535,383,000USD | 495,007,000USD | 457,489,000USD | 438,436,000USD | 437,006,000USD |
| Total Equity Including Noncontrolling Interest | 654,149,000USD | — | — | — | — | — | — | — |
| Deferred Revenue Non Current | 31,811,000USD | — | — | — | — | — | — | — |
| Net Receivables | 23,490,000USD | 23,224,000USD | 15,594,000USD | 51,742,000USD | 31,910,000USD | 40,065,000USD | 41,724,000USD | 24,888,000USD |
| Inventory | 70,930,000USD | 73,141,000USD | 54,895,000USD | 41,396,000USD | 48,181,000USD | 22,069,000USD | 26,364,000USD | 28,680,000USD |
| Property Plant Equipment Net | 10,928,000USD | 11,320,000USD | 11,750,000USD | 11,728,000USD | 11,380,000USD | 11,059,000USD | 11,038,000USD | 11,656,000USD |
| Accounts Payable | 12,404,000USD | 24,402,000USD | 2,028,000USD | 6,150,000USD | 8,956,000USD | 1,982,000USD | 2,039,000USD | 8,328,000USD |
| Short Term Debt | 4,012,000USD | 3,170,000USD | 2,987,000USD | 2,696,000USD | 2,522,000USD | 2,292,000USD | 1,993,000USD | 2,031,000USD |
| Retained Earnings | -414,114,000USD | -439,546,000USD | -462,138,000USD | -476,337,000USD | -494,772,000USD | -512,604,000USD | -521,143,000USD | -512,255,000USD |
| Accumulated Other Comprehensive Income | -1,380,000USD | -665,000USD | -25,000USD | -155,000USD | -53,000USD | -165,000USD | -163,000USD | -41,000USD |
| Intangible Assets | — | 15,000,000USD | 15,250,000USD | 15,500,000USD | 15,750,000USD | 16,000,000USD | 16,250,000USD | 16,500,000USD |
| Total Liab | — | 219,593,000USD | 196,027,000USD | 176,950,000USD | 166,143,000USD | 141,837,000USD | 142,117,000USD | 118,292,000USD |
| Other Current Liab | — | 129,039,000USD | 102,358,000USD | 114,746,000USD | 74,538,000USD | 92,993,000USD | 96,589,000USD | 85,596,000USD |
| Common Stock | — | 21,000USD | 21,000USD | 21,000USD | 21,000USD | 20,000USD | 20,000USD | 20,000USD |
| Capital Stock | — | 21,000USD | 21,000USD | 21,000USD | 21,000USD | 20,000USD | 20,000USD | 20,000USD |
| Cash | — | 189,952,000USD | 165,596,000USD | 174,858,000USD | 192,037,000USD | 157,132,000USD | 183,581,000USD | 97,376,000USD |
| Net Debt | — | -180,927,000USD | -156,099,000USD | -165,140,000USD | -182,272,000USD | -147,217,000USD | -173,726,000USD | -86,781,000USD |
| Short Long Term Debt Total | — | 9,025,000USD | 9,497,000USD | 9,718,000USD | 9,765,000USD | 9,915,000USD | 9,855,000USD | 10,595,000USD |
| Property Plant Equipment Gross | — | 18,694,000USD | 18,980,000USD | 19,546,000USD | 19,157,000USD | 18,838,000USD | 19,231,000USD | 19,761,000USD |
| Common Stock Shares Outstanding | — | 82,409,703shares | 78,979,030shares | 78,027,370shares | 77,942,000shares | 76,145,617shares | 72,319,000shares | 71,727,000shares |
| Non Current Assets Total | — | 231,108,000USD | 236,456,000USD | 236,803,000USD | 240,839,000USD | 243,419,000USD | 248,754,000USD | 243,997,000USD |
| Non Current Liabilities Total | — | 62,982,000USD | 56,843,000USD | 53,358,000USD | 48,316,000USD | 44,570,000USD | 41,496,000USD | 22,337,000USD |
| Non Current Liabilities Other | — | 25,316,000USD | 18,522,000USD | 14,525,000USD | 9,262,000USD | 5,136,000USD | 1,823,000USD | 1,962,000USD |
| Non Currrent Assets Other | — | 11,162,000USD | 11,307,000USD | 8,288,000USD | 8,195,000USD | 8,202,000USD | 10,315,000USD | 7,853,000USD |
| Net Working Capital | — | 437,561,000USD | 387,993,000USD | 351,938,000USD | 302,484,000USD | 258,640,000USD | 231,178,000USD | 215,346,000USD |
| Unclassified Non Current Assets | — | 193,626,000USD | 198,149,000USD | 201,287,000USD | 205,514,000USD | 208,158,000USD | 211,151,000USD | 207,988,000USD |
| Unclassified Non Current Liabilities | — | 37,666,000USD | 38,321,000USD | 38,833,000USD | 39,054,000USD | 39,434,000USD | 39,673,000USD | 20,375,000USD |
| Unclassified Equity | — | 1,045,856,000USD | 1,029,727,000USD | 1,011,833,000USD | 989,790,000USD | 970,218,000USD | 959,702,000USD | 949,262,000USD |
| Current Deferred Revenue | — | — | 31,811,000USD | — | 31,811,000USD | 31,811,000USD | -1,993,000USD | 11,811,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | -31,811,000USD | — | -11,811,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 763,633,000USD | 580,553,000USD | 526,322,000USD | 459,672,000USD | 232,800,000USD | 349,464,000USD | 254,534,000USD | 321,965,000USD |
| Intangible Assets | 15,250,000USD | 16,250,000USD | 17,250,000USD | 18,250,000USD | 19,250,000USD | — | — | — |
| Other Current Assets | 42,614,000USD | 20,084,000USD | 17,538,000USD | 10,537,000USD | 6,585,000USD | 9,767,000USD | 8,247,000USD | 12,892,000USD |
| Total Liab | 196,027,000USD | 142,117,000USD | 87,483,000USD | 63,523,000USD | 47,763,000USD | 37,529,000USD | 29,111,000USD | 42,698,000USD |
| Total Stockholder Equity | 567,606,000USD | 438,436,000USD | 438,839,000USD | 396,149,000USD | 185,037,000USD | 311,935,000USD | 225,423,000USD | -194,225,000USD |
| Other Current Liab | 102,358,000USD | 96,589,000USD | 52,860,000USD | 35,866,000USD | 39,575,000USD | 29,236,000USD | 20,440,000USD | 31,636,000USD |
| Common Stock | 21,000USD | 20,000USD | 20,000USD | 19,000USD | 18,000USD | 18,000USD | 15,000USD | 13,000USD |
| Capital Stock | 21,000USD | 20,000USD | 20,000USD | 19,000USD | 18,000USD | 18,000USD | 15,000USD | 13,000USD |
| Retained Earnings | -462,138,000USD | -521,143,000USD | -477,950,000USD | -492,034,000USD | -675,397,000USD | -517,473,000USD | -356,092,000USD | -194,225,000USD |
| Cash | 165,596,000USD | 183,581,000USD | 107,954,000USD | 122,715,000USD | 122,470,000USD | 114,038,000USD | 46,928,000USD | 307,304,000USD |
| Cash And Short Term Investments | 414,074,000USD | 243,627,000USD | 206,371,000USD | 190,608,000USD | 182,201,000USD | 323,482,000USD | 233,380,000USD | 307,304,000USD |
| Total Current Assets | 527,177,000USD | 331,799,000USD | 276,297,000USD | 243,060,000USD | 196,446,000USD | 333,249,000USD | 241,627,000USD | 313,750,000USD |
| Total Current Liabilities | 139,184,000USD | 100,621,000USD | 63,666,000USD | 47,066,000USD | 44,824,000USD | 31,846,000USD | 27,830,000USD | 42,554,000USD |
| Current Deferred Revenue | 31,811,000USD | 31,811,000USD | 307,000USD | 12,000,000USD | 38,031,000USD | 29,199,000USD | 20,415,000USD | — |
| Net Debt | -156,099,000USD | -173,726,000USD | -95,696,000USD | -116,796,000USD | -116,420,000USD | -107,053,000USD | -44,276,000USD | -307,304,000USD |
| Short Term Debt | 2,987,000USD | 1,993,000USD | 2,253,000USD | 3,301,000USD | 3,381,000USD | 2,107,000USD | 1,697,000USD | — |
| Short Long Term Debt Total | 9,497,000USD | 9,855,000USD | 12,258,000USD | 5,919,000USD | 6,050,000USD | 6,985,000USD | 2,652,000USD | — |
| Short Term Investments | 248,478,000USD | 60,046,000USD | 98,417,000USD | 67,893,000USD | 59,731,000USD | 209,444,000USD | 186,452,000USD | 235,328,000USD |
| Net Receivables | 15,594,000USD | 41,724,000USD | 21,266,000USD | 20,316,000USD | 3,985,000USD | 0USD | — | — |
| Inventory | 54,895,000USD | 26,364,000USD | 31,122,000USD | 21,599,000USD | 3,675,000USD | 0USD | — | — |
| Accounts Payable | 2,028,000USD | 2,039,000USD | 8,246,000USD | 7,899,000USD | 1,868,000USD | 503,000USD | 5,693,000USD | 10,918,000USD |
| Property Plant Equipment Net | 11,750,000USD | 11,038,000USD | 12,665,000USD | 7,043,000USD | 8,384,000USD | 10,617,000USD | 8,325,000USD | 6,356,000USD |
| Property Plant Equipment Gross | 18,980,000USD | 19,231,000USD | 20,450,000USD | 13,902,000USD | 14,299,000USD | 10,617,000USD | 8,325,000USD | 6,356,000USD |
| Accumulated Other Comprehensive Income | -25,000USD | -163,000USD | 6,000USD | 44,000USD | -66,000USD | -34,000USD | 33,000USD | -4,000USD |
| Common Stock Shares Outstanding | 78,979,030shares | 71,424,000shares | 71,922,915shares | 70,421,322shares | 68,576,810shares | 61,842,722shares | 54,049,477shares | 29,547,427shares |
| Non Current Assets Total | 236,456,000USD | 248,754,000USD | 250,025,000USD | 216,612,000USD | 36,354,000USD | 16,215,000USD | 12,907,000USD | 8,215,000USD |
| Non Current Liabilities Total | 56,843,000USD | 41,496,000USD | 23,817,000USD | 16,457,000USD | 2,939,000USD | 5,683,000USD | 1,281,000USD | 144,000USD |
| Non Current Liabilities Other | 18,522,000USD | 1,823,000USD | 1,858,000USD | 16,457,000USD | 2,939,000USD | 5,683,000USD | 326,000USD | 144,000USD |
| Non Currrent Assets Other | 11,307,000USD | 10,315,000USD | 827,000USD | 5,824,000USD | 8,720,000USD | 5,588,000USD | 210,000USD | 643,000USD |
| Net Working Capital | 387,993,000USD | 231,178,000USD | 212,631,000USD | 195,994,000USD | 151,622,000USD | 301,403,000USD | 213,797,000USD | 271,196,000USD |
| Unclassified Non Current Assets | 198,149,000USD | 211,151,000USD | 219,282,999USD | -5,824,000USD | -8,720,000USD | -12,154,000USD | — | — |
| Unclassified Non Current Liabilities | 38,321,000USD | 39,673,000USD | 21,959,000USD | -13,839,000USD | — | — | — | — |
| Unclassified Equity | 1,029,727,000USD | 959,702,000USD | 916,743,000USD | 888,101,000USD | 860,464,000USD | 829,406,000USD | 581,452,000USD | — |
| Unclassified Current Liabilities | — | -31,811,000USD | — | -12,000,000USD | -38,031,000USD | -29,199,000USD | -20,415,000USD | — |
| Other Assets | — | — | 1USD | 191,319,000USD | 8,720,000USD | 12,164,000USD | 4,582,000USD | 1,859,000USD |
| Other Liab | — | — | — | 13,839,000USD | 270,000USD | 805,000USD | 326,000USD | 144,000USD |
| Net Tangible Assets | — | — | — | 377,899,000USD | 194,548,000USD | 311,935,000USD | 225,423,000USD | 279,267,000USD |
| Deferred Long Term Liab | — | — | — | — | — | — | — | 433,000USD |
| Unclassified Current Assets | — | — | — | — | — | — | — | -241,774,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 940,000USD |
| Stock Based Compensation | 21,692,000USD |
| Deferred Income Tax | 7,184,000USD |
| Change To Account Receivables | -7,896,000USD |
| Change To Inventory | -16,035,000USD |
| Change To Liabilities | 46,417,000USD |
| Change In Working Capital | -18,813,000USD |
| Operating Cash Flow | 97,394,000USD |
| Capital Expenditures | -824,000USD |
| Unclassified Investing Cash Flow | -104,672,000USD |
| Investing Cash Flow | -105,496,000USD |
| Net Common Stock Issuance | -5,784,000USD |
| Unclassified Financing Cash Flow | 23,967,000USD |
| Financing Cash Flow | 18,183,000USD |
| Change In Cash | 10,081,000USD |
| End Cash Flow | 175,677,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 22,592,000USD | 18,435,000USD | 17,832,000USD | 8,539,000USD | -8,888,000USD | -12,693,000USD | -3,908,000USD | -17,704,000USD |
| Depreciation | 1,770,000USD | 384,000USD | 358,000USD | 345,000USD | 400,000USD | 399,000USD | 430,000USD | 466,000USD |
| Stock Based Compensation | 10,056,000USD | 10,144,000USD | 8,876,000USD | 7,748,000USD | 8,298,000USD | 7,826,000USD | 7,363,000USD | 7,206,000USD |
| Other Non Cash Items | 940,000USD | 1,504,000USD | 46,000USD | 1,100,000USD | 1,586,000USD | 267,000USD | 624,000USD | 1,076,000USD |
| Change To Account Receivables | -7,630,000USD | -19,832,000USD | 8,155,000USD | 1,659,000USD | -16,836,000USD | -4,437,000USD | -4,456,000USD | 5,271,000USD |
| Change To Inventory | -18,246,000USD | 6,785,000USD | -26,112,000USD | 4,295,000USD | 2,316,000USD | 6,178,000USD | -7,580,000USD | 3,844,000USD |
| Change In Working Capital | 10,318,000USD | -1,017,000USD | -1,666,000USD | 1,599,000USD | 20,537,000USD | 5,604,000USD | -9,910,000USD | 8,578,000USD |
| Total Cash From Operating Activities | 50,199,000USD | 33,677,000USD | 28,090,000USD | 22,324,000USD | 18,770,000USD | -2,236,000USD | 5,168,000USD | 3,987,000USD |
| Capital Expenditures | -161,000USD | -671,000USD | -165,000USD | -99,000USD | -193,000USD | 0USD | 0USD | -84,000USD |
| Free Cash Flow | 50,038,000USD | 33,006,000USD | 27,925,000USD | 22,225,000USD | 18,577,000USD | -2,236,000USD | 5,168,000USD | 3,903,000USD |
| Investments | -31,755,000USD | -62,755,000USD | -3,883,000USD | -51,541,000USD | 65,293,000USD | -6,348,000USD | -46,797,000USD | 25,524,000USD |
| Total Cashflows From Investing Activities | -31,916,000USD | -62,755,000USD | -3,883,000USD | -51,541,000USD | 65,293,000USD | -6,348,000USD | -46,797,000USD | 25,524,000USD |
| Total Cash From Financing Activities | 6,073,000USD | 11,899,000USD | 10,698,000USD | 2,768,000USD | 2,142,000USD | 6,689,000USD | -178,000USD | 3,613,000USD |
| Sale Purchase Of Stock | -316,000USD | -4,353,000USD | -2,047,000USD | -412,000USD | -578,000USD | -2,712,000USD | -1,313,000USD | -381,000USD |
| Change In Cash | 24,356,000USD | -17,179,000USD | 34,905,000USD | -26,449,000USD | 86,205,000USD | -1,895,000USD | -41,807,000USD | 33,124,000USD |
| Begin Period Cash Flow | 165,596,000USD | 192,037,000USD | 157,132,000USD | 183,581,000USD | 97,376,000USD | 99,271,000USD | 141,078,000USD | 107,954,000USD |
| End Period Cash Flow | 189,952,000USD | 174,858,000USD | 192,037,000USD | 157,132,000USD | 183,581,000USD | 97,376,000USD | 99,271,000USD | 141,078,000USD |
| Other Cashflows From Financing Activities | 6,073,000USD | 16,252,000USD | 12,745,000USD | 3,180,000USD | 2,720,000USD | 9,401,000USD | 1,135,000USD | 3,994,000USD |
| Unclassified Operating Cash Flow | 4,523,000USD | 4,227,000USD | 2,644,000USD | 2,993,000USD | -3,163,000USD | -3,639,000USD | 10,569,000USD | 4,365,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | 25,000USD | 25,000USD | 25,608,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | — | -25,524,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -43,193,000USD | 14,084,000USD | 183,363,000USD | -157,924,000USD | -161,381,000USD | -161,867,000USD | -103,227,000USD | -64,873,000USD |
| Depreciation | 1,695,000USD | 2,341,000USD | 2,402,000USD | 2,355,000USD | 2,405,000USD | 2,068,000USD | 286,000USD | 28,000USD |
| Stock Based Compensation | 30,693,000USD | 27,149,000USD | 25,120,000USD | 25,173,000USD | 20,875,000USD | 15,080,000USD | 5,701,000USD | 897,000USD |
| Other Non Cash Items | 3,553,000USD | 2,165,000USD | 2,992,000USD | 3,398,000USD | 1,523,000USD | 6,531,000USD | -1,122,000USD | -52,999USD |
| Change To Account Receivables | -20,458,000USD | -950,000USD | -16,331,000USD | -3,910,000USD | -3,910,000USD | -3,910,000USD | -3,910,000USD | — |
| Change To Inventory | 4,758,000USD | -9,523,000USD | -17,924,000USD | -3,675,000USD | -3,675,000USD | -3,675,000USD | -3,675,000USD | — |
| Change In Working Capital | 24,809,000USD | 1,350,000USD | -22,575,000USD | 689,000USD | -4,315,000USD | -17,025,000USD | 18,328,000USD | 13,926,000USD |
| Total Cash From Operating Activities | 25,689,000USD | 13,301,000USD | 5,807,000USD | -126,298,000USD | -136,532,000USD | -158,369,000USD | -81,012,000USD | -50,219,000USD |
| Capital Expenditures | -277,000USD | -130,000USD | -105,000USD | -20,415,000USD | -283,000USD | -3,203,000USD | -5,290,000USD | -69,000USD |
| Free Cash Flow | 25,412,000USD | 13,171,000USD | 5,702,000USD | -146,713,000USD | -136,815,000USD | -161,572,000USD | -86,302,000USD | -50,288,000USD |
| Investments | 37,672,000USD | -57,323,000USD | -8,064,000USD | 149,050,000USD | -23,161,000USD | 52,417,000USD | -233,908,000USD | -69,000USD |
| Total Cashflows From Investing Activities | 37,672,000USD | -29,557,000USD | -8,078,000USD | 128,635,000USD | -23,444,000USD | 49,214,000USD | -239,198,000USD | -69,000USD |
| Total Cash From Financing Activities | 12,266,000USD | 1,495,000USD | 2,516,000USD | 5,885,000USD | 227,086,000USD | 84,107,000USD | 346,736,000USD | 39,873,000USD |
| Sale Purchase Of Stock | -4,984,000USD | -2,206,000USD | -901,000USD | 5,885,000USD | 6,553,000USD | 84,225,000USD | 350,393,000USD | 39,873,000USD |
| Change In Cash | 75,627,000USD | -14,761,000USD | 245,000USD | 8,222,000USD | 67,110,000USD | -25,048,000USD | 26,526,000USD | -10,415,000USD |
| Begin Period Cash Flow | 107,954,000USD | 122,715,000USD | 122,470,000USD | 114,248,000USD | 47,138,000USD | 72,186,000USD | 45,660,000USD | 56,075,000USD |
| End Period Cash Flow | 183,581,000USD | 107,954,000USD | 122,715,000USD | 122,470,000USD | 114,248,000USD | 47,138,000USD | 72,186,000USD | 45,660,000USD |
| Other Cashflows From Investing Activities | 25,000USD | — | 91,000USD | -20,000,000USD | -23,161,000USD | 52,417,000USD | -233,908,000USD | — |
| Other Cashflows From Financing Activities | 17,250,000USD | 3,701,000USD | -901,000USD | 5,885,000USD | -1,136,000USD | 1,001,000USD | 187,542,000USD | 39,873,000USD |
| Unclassified Operating Cash Flow | 8,132,000USD | -33,788,000USD | -185,495,000USD | — | 4,361,000USD | -3,156,000USD | — | — |
| Unclassified Investing Cash Flow | — | 27,896,000USD | — | 20,000,000USD | 23,161,000USD | -52,417,000USD | 233,908,000USD | — |
| Change To Liabilities | — | — | 15,891,000USD | 11,170,000USD | 4,306,000USD | 259,000USD | 18,119,000USD | 1,006,000USD |
| Issuance Of Capital Stock | — | — | 3,417,000USD | 5,885,000USD | 221,669,000USD | 83,106,000USD | 350,016,000USD | — |
| Cash And Cash Equivalents Changes | — | — | 245,000USD | 8,222,000USD | 67,110,000USD | -25,048,000USD | 26,526,000USD | — |
| Unclassified Financing Cash Flow | — | — | 4,318,000USD | -5,885,000USD | 221,669,000USD | -1,119,000USD | -191,199,000USD | -39,873,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | Collaboration | 0 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Product | 243,600,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | Collaboration | 0 | USD | 0001104659-26-050359 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product | 214,266,000 | USD | 0001104659-26-050359 |
| Q4 2025Quarterly · 2025-12-31 | Product | Collaboration | 0 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Product | 202,127,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Collaboration | 0 | USD | 0001104659-26-019168 |
| FY 2025Yearly · 2025-12-31 | Product | Product | 677,564,000 | USD | 0001104659-26-019168 |
| Q3 2025Quarterly · 2025-09-30 | Product | Collaboration | 0 | USD | 0001104659-25-103180 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product | 180,855,000 | USD | 0001104659-25-103180 |
| Q2 2025Quarterly · 2025-06-30 | Product | Collaboration | 0 | USD | 0001558370-25-009738 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product | 156,797,000 | USD | 0001558370-25-009738 |
| Q1 2025Quarterly · 2025-03-31 | Product | Collaboration | 0 | USD | 0001104659-26-050359 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product | 137,785,000 | USD | 0001104659-26-050359 |
| Q4 2024Quarterly · 2024-12-31 | Product | Collaboration | 0 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Product | 122,536,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | Collaboration | 6,210,000 | USD | 0001104659-26-019168 |
| FY 2024Yearly · 2024-12-31 | Product | Product | 417,029,000 | USD | 0001104659-26-019168 |
| Q3 2024Quarterly · 2024-09-30 | Product | Collaboration | 0 | USD | 0001104659-25-103180 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product | 112,214,000 | USD | 0001104659-25-103180 |
| FY 2023Yearly · 2023-12-31 | Product | Collaboration | 37,083,000 | USD | 0001104659-26-019168 |
| FY 2023Yearly · 2023-12-31 | Product | Product | 233,176,000 | USD | 0001104659-26-019168 |
| FY 2022Yearly · 2022-12-31 | Product | Collaboration | 97,656,000 | USD | 0001558370-25-001505 |
| FY 2022Yearly · 2022-12-31 | Product | Product | 122,524,000 | USD | 0001558370-25-001505 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.